Literature DB >> 7976501

Upregulation of c-fos protooncogene expression in pagetic osteoclasts.

J Hoyland1, P T Sharpe.   

Abstract

Using in situ hybridization we show that expression of the c-fos oncogene, a gene normally associated with osteosarcomas, is greatly elevated in osteoclasts of patients with Paget's disease. Immunohistochemical staining with c-fos antibodies also shows increased protein in pagetic osteoclasts. In light of transgenic mouse experiments showing a key role for c-fos in bone resorption, we propose that elevated c-fos gene expression in pagetic osteoclasts is an important component in producing the pagetic phenotype. Levels of c-fos gene and protein expression in pagetic osteoblasts are lower than those detected in osteoclasts but still higher than in nonpagetic osteoblasts. This may provide an explanation for the increased incidence of osteosarcomas in patients with Paget's disease because overexpression of c-fos in osteoblasts of transgenic mice induces osteosarcoma formation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7976501     DOI: 10.1002/jbmr.5650090808

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  8 in total

Review 1.  Paget's disease of bone: a disease of the osteoclast.

Authors:  S V Reddy; N Kurihara; C Menaa; G D Roodman
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

Review 2.  The contribution of Sir James Paget (1814-1894) to the study of rheumatic disease.

Authors:  W Buchanan
Journal:  Clin Rheumatol       Date:  1996-09       Impact factor: 2.980

Review 3.  Paget's disease of bone.

Authors:  C G Ooi; W D Fraser
Journal:  Postgrad Med J       Date:  1997-02       Impact factor: 2.401

4.  Aberrant P-cadherin expression is an early event in hyperplastic and dysplastic transformation in the colon.

Authors:  R G Hardy; C Tselepis; J Hoyland; Y Wallis; T P Pretlow; I Talbot; D S A Sanders; G Matthews; D Morton; J A Z Jankowski
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

5.  Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone.

Authors:  Kumaran Sundaram; Srinivasan Shanmugarajan; D Sudhaker Rao; Sakamuri V Reddy
Journal:  Endocrinology       Date:  2011-08-30       Impact factor: 4.736

Review 6.  RSK in tumorigenesis: connections to steroid signaling.

Authors:  T S Karin Eisinger-Mathason; Josefa Andrade; Deborah A Lannigan
Journal:  Steroids       Date:  2010-01-04       Impact factor: 2.668

Review 7.  Epidemiology and pathology of Paget's disease of bone - a review.

Authors:  Elena Nebot Valenzuela; Peter Pietschmann
Journal:  Wien Med Wochenschr       Date:  2016-09-06

8.  Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix.

Authors:  Stefan M Willems; Alex B Mohseny; Crina Balog; Raj Sewrajsing; Inge H Briaire-de Bruijn; Jeroen Knijnenburg; Anne-Marie Cleton-Jansen; Raf Sciot; Christopher D M Fletcher; André M Deelder; Karoly Szuhai; Paul J Hensbergen; Pancras C W Hogendoorn
Journal:  J Cell Mol Med       Date:  2009-03-13       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.